Omeprazole, a drug belonging to proton pump inhibitors (PPIs) class, is used to decrease the amount of acid produced in the stomach. It was discovered in 1979 and appears on the World Health Organizations’ List of Essential Medicines. According to the NHS Business Services Authority (NHSBSA) statistics, over 2 million items of omeprazole were prescribed in the U.K. in March 2018 alone. It is one of the most prescribed medications across the globe. According to drug usage statistics published by ClinCalc, the number of omeprazole prescription in the U. S. increased from 26 million to 70 million from 2006 to 2016. Omeprazole is used alone or prescribed in combination with other medications. It is used to treat gastroesophageal reflux disease (GERD), ulcers, and other conditions caused due to excessive stomach acid. Frequent flow of stomach acid into the esophagus, which irritates the lining of esophagus, can cause GERD. Omeprazole is used with other medications in treatment of infections caused by H. pylori bacteria. The common side effects of omeprazole include tomach pain, flatulence, nausea, vomiting, diarrhea, and headache. Increase in prevalence of peptic and duodenal ulcers and rise in awareness regarding gastrointestinal disorder in developing countries are expected to propel the omeprazole market during the forecast period. Side effects associated with omeprazole are likely to hamper the omeprazole market during the forecast period. 

The global omeprazole market can be segmented based on dosage form, indication, distribution channel, and region. In terms of dosage form, the omeprazole market can be classified into capsule, powder, tablet, and suspension. The tablet segment held a dominant share of the market in 2017 and is expected to continue this trend during the forecast period, as tablets are inexpensive, easy to handle, and coated with sugar to mask the unpleasant taste.

Based on indication, the global omeprazole market can be segregated into duodenal ulcers, gastric ulcers, GERD, erosive esophagitis, and others. The duodenal ulcers segment dominated the market in 2017 due high prevalence of these ulcers across the globe. The segment is expected to continue to account for a large share of the omeprazole market during the forecast period. In terms of distribution channel, the global omeprazole market can be divided into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment dominated the market in 2017 due to easy availability of medications in hospitals. The segment is expected to continue to dominate the omeprazole market from 2018 to 2026. 

Based on region, the global omeprazole market can be categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2017 due to the increase in incidences of H.pylori infection, which cause ulcers. Peptic ulcer disease (PUD) affects approximately 4.5 million people in the U.S. annually. Approximately 10% of the U.S. population suffer from duodenal ulcer. The market in Asia Pacific is anticipated to expand at a substantial CAGR owing to the rise in prevalence of H.pylori infection. 

Major players operating in the global omeprazole market include Zydus Cadila, Sandoz International GmbH, Apotex Inc., AstraZeneca, Dr. Reddy’s Laboratories Ltd., Perrigo Company plc., Impax Laboratories, LLC, and Mylan N.V.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

.